Facebook pixelSelleckChem - small molecule inhibitors & libraries - LubioScience GmbH

SelleckChem

SelleckChem is one of the world leading suppliers of small molecules, inhibitors and inhibitor libraries, with a portfolio of more than 8,000 products. These are directed at diverse signaling pathways, such as MAPK, PI3K/Akt or apoptosis. Compound libraries for high-throughput screening and high-content screening are also available.

Product offering

  • Small molecules
  • Kinase inhibitors
  • Pathway inhibitors
  • Protease inhibitors
  • Kinase inhibitor libraries
  • FDA-approved drug libraries
  • Natural compound libraries
  • Cambridge and Pfizer based compound libraries

Screening libraries

LibraryCat-No.Size 
Bioactive Compound LibraryL1700-100UL/WELL100 μl/well 
Kinase Inhibitor LibraryL1200-100UL/WELL100 μl/well 
Inhibitor LibraryL1100-100UL/WELL100 μl/well 
Epigenetics Compound LibraryL1900-100UL/WELL100 μl/well 
Natural Product LibraryL1400-100UL/WELL100 μl/well
Anti-cancer Compound LibraryL3000-100UL/WELL100 μl/well
PI3K/Akt Inhibitor LibraryL2800-100UL/WELL100 μl/well
Protease Inhibitor LibraryL2500-100UL/WELL100 μl/well

FDA-approved drug library

  • 1163 FDA-approved drugs
  • A unique collection of 1'163 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS)

Advantages

  • NMR and HPLC validated to ensure high purity
  • All compounds have been approved by FDA
  • Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc
  • Structurally diverse, medicinally active, and cell permeable
  • Rich documentation with structure, IC50, and customer reviews
  • Two-dimensional bar code available in SDF and XLSF files
LibraryCat-No.Size         
FDA-approved Drug LibraryL1300-100UL/WELL100 μl/well
FDA-approved Drug Library L1300-250UL/WELL250 μl/well